In this study, we found that the presence of omental CD68+ or CD163+ CLSs is associated with poor prognosis in advanced-stage HGSOC, though the density of ovarian tumor TAMs was not associated with patient survival in our cohort. This evidence concerns the gene CD68 and ovarian neoplasm.